Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Danaher Corporation

DHR ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Advanced Medical Equipment & Technology ·

USA Large Cap Analyst: BUY

Last Close

$200.14

▼ -0.19%

Market Cap $140.70B · Vol 772.64K

Key Metrics

P/E Ratio

35.66

FWD: 22.12

Market Cap

$140.70B

Large Cap

Div Yield

0.80%

Quarterly dividend

EPS Growth

+9.05%

YoY

RSI (14)

18.87

Momentum

Beta

0.78

vs Market

52W High

$242.80

17.57% below

52W Low

$160.93

24.36% above

Volume

772.64K

Avg 891.75K

P/B

3.08

Price-to-book

ROE

10.94%

Return on equity

Free Float

89.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Danaher Corporation (DHR) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DHR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.16%

-3.52%

+10.70%

+2.60%

YTD

-12.57%

+2.55%

-9.08%

-31.58%

Financials & Valuation

TTM · Annual

Total Revenue	$24.57B
Net Income	$3.60B
Revenue Growth (YoY)	+5.54%
Gross Margin	59.23%
Operating Margin	21.91%
Net Profit Margin	14.65%
ROE	10.94%
ROA · ROIC	5.26% · 5.62%

P/E Ratio	35.66
Forward P/E (FY1)	22.12
PEG Ratio	-9.91
P/S	6.67
P/B	3.08
P/FCF	31.17
EPS Growth	+9.05%
Outstanding Shares	702.99M

Technical Indicators

50-Day SMA	$202.38
200-Day SMA	$202.39
RSI (14)	18.87
Beta	0.78
52-Week High	$242.80
52-Week Low	$160.93

Volume Today	772.64K
Avg Daily Volume (30D)	891.75K
Relative Volume	0.87x
Volatility (10D)	20.42
Volatility (30D)	27.52
Free Float	89.00%

Analyst Consensus

BUY

Current Price $200.14

Mean Target $226.74

52W Low$160.93 52W High$242.80

Current

Target

$160.93 $242.80

Current Analyst target

+13.29% upside potential · 28 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S5QGT0

ISINUS2358511028

CountryUSA

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 19, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc +1.10% ISRG Intuitive Surgical, Inc. +2.41% BSX Boston Scientific Corp -0.28% SHL.DE Siemens Healthineers AG -0.49% EW Edwards Lifesciences Corporation -2.77%

Company Profile

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services. The Company also provides pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings.